Stroke volume variation during acute normovolemic hemodilution

Gudrun Kungys, David D. Rose, Neal Fleming

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND: The intravascular volume of surgical patients should be optimized to avoid complications associated with both overhydration and underresuscitation. In patients undergoing intraoperative acute normovolemic hemodilution, we investigated whether stroke volume variation (SVV) derived from an arterial pressure-based cardiac output (CO) monitor system (FloTrac/Vigileo™, Edwards Lifesciences, Irvine, CA) tracked the changes associated with blood removal and replacement. We further evaluated the correlations between SVV and 3-dimensional (3D) transesophageal echocardiographic (TEE) left ventricular (LV) volume measurements. METHODS: Twenty-five patients had procedures during which acute normovolemic hemodilution was a planned part of the intraoperative management. We defined 7 measurement timepoints: baseline, after the removal of 5%, 10%, and 15% of the estimated blood volume (EBV) and after replacement with an equal volume of 6% hetastarch to -10%, -5%, and baseline EBV. At each timepoint, heart rate and systolic, diastolic, and mean arterial blood pressure were obtained from standard monitors, CO and SVV measurements were obtained from the FloTrac/Vigileo monitor, and TEE images were recorded for subsequent off-line reconstruction and determination of LV end-systolic and end-diastolic volumes. For statistical evaluations, we used a mixed models analysis of variance and Dunnett's test for post hoc comparisons with baseline values. Pearson's correlation was used to examine the relationships between SVV and LV volume. RESULTS: Analysis of variance demonstrated no significant change in heart rate or mean arterial blood pressure over the duration of study. CO decreased from 4.9 ± 0.3 to 4.5 ± 0.3 L/min after removal of 15% of the EBV and then increased to a final value of 5.4 ± 0.3 L/min after replacement of 15% of the EBV. SVV increased from 9.2% ± 0.9% to 20.3% ± 2.0% (P < 0.001) after removal of 15% of the EBV and returned to a final value of 7.2% ± 0.9% after replacement of 15% of the EBV. The indexed LV end-diastolic volume decreased from 42.1 ± 8.3 to 36.9.3 ± 8.3 mL/m (P < 0.001) after removal of 15% of the EBV and then returned to a final volume of 45.9 ± 10.3 mL/m after replacement of 15% of the EBV. The measurements of SVV correlated inversely with the 3D TEE LV volume measurements. CONCLUSIONS: The SVV derived from the FloTrac/Vigileo system changes significantly as blood is removed and replaced during hemodilution. These changes correlate with 3D TEE measurements of LV volume. The utility of SVV in guiding optimization of intravascular volume merits further study.

Original languageEnglish (US)
Pages (from-to)1823-1830
Number of pages8
JournalAnesthesia and Analgesia
Volume109
Issue number6
DOIs
StatePublished - Dec 2009

Fingerprint

Hemodilution
Stroke Volume
Blood Volume
Arterial Pressure
Cardiac Output
Analysis of Variance
Heart Rate
Hydroxyethyl Starch Derivatives
Cardiac Volume

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Stroke volume variation during acute normovolemic hemodilution. / Kungys, Gudrun; Rose, David D.; Fleming, Neal.

In: Anesthesia and Analgesia, Vol. 109, No. 6, 12.2009, p. 1823-1830.

Research output: Contribution to journalArticle

Kungys, Gudrun ; Rose, David D. ; Fleming, Neal. / Stroke volume variation during acute normovolemic hemodilution. In: Anesthesia and Analgesia. 2009 ; Vol. 109, No. 6. pp. 1823-1830.
@article{388a854d8de14cff9c8270efc56aac7e,
title = "Stroke volume variation during acute normovolemic hemodilution",
abstract = "BACKGROUND: The intravascular volume of surgical patients should be optimized to avoid complications associated with both overhydration and underresuscitation. In patients undergoing intraoperative acute normovolemic hemodilution, we investigated whether stroke volume variation (SVV) derived from an arterial pressure-based cardiac output (CO) monitor system (FloTrac/Vigileo™, Edwards Lifesciences, Irvine, CA) tracked the changes associated with blood removal and replacement. We further evaluated the correlations between SVV and 3-dimensional (3D) transesophageal echocardiographic (TEE) left ventricular (LV) volume measurements. METHODS: Twenty-five patients had procedures during which acute normovolemic hemodilution was a planned part of the intraoperative management. We defined 7 measurement timepoints: baseline, after the removal of 5{\%}, 10{\%}, and 15{\%} of the estimated blood volume (EBV) and after replacement with an equal volume of 6{\%} hetastarch to -10{\%}, -5{\%}, and baseline EBV. At each timepoint, heart rate and systolic, diastolic, and mean arterial blood pressure were obtained from standard monitors, CO and SVV measurements were obtained from the FloTrac/Vigileo monitor, and TEE images were recorded for subsequent off-line reconstruction and determination of LV end-systolic and end-diastolic volumes. For statistical evaluations, we used a mixed models analysis of variance and Dunnett's test for post hoc comparisons with baseline values. Pearson's correlation was used to examine the relationships between SVV and LV volume. RESULTS: Analysis of variance demonstrated no significant change in heart rate or mean arterial blood pressure over the duration of study. CO decreased from 4.9 ± 0.3 to 4.5 ± 0.3 L/min after removal of 15{\%} of the EBV and then increased to a final value of 5.4 ± 0.3 L/min after replacement of 15{\%} of the EBV. SVV increased from 9.2{\%} ± 0.9{\%} to 20.3{\%} ± 2.0{\%} (P < 0.001) after removal of 15{\%} of the EBV and returned to a final value of 7.2{\%} ± 0.9{\%} after replacement of 15{\%} of the EBV. The indexed LV end-diastolic volume decreased from 42.1 ± 8.3 to 36.9.3 ± 8.3 mL/m (P < 0.001) after removal of 15{\%} of the EBV and then returned to a final volume of 45.9 ± 10.3 mL/m after replacement of 15{\%} of the EBV. The measurements of SVV correlated inversely with the 3D TEE LV volume measurements. CONCLUSIONS: The SVV derived from the FloTrac/Vigileo system changes significantly as blood is removed and replaced during hemodilution. These changes correlate with 3D TEE measurements of LV volume. The utility of SVV in guiding optimization of intravascular volume merits further study.",
author = "Gudrun Kungys and Rose, {David D.} and Neal Fleming",
year = "2009",
month = "12",
doi = "10.1213/ANE.0b013e3181ba41af",
language = "English (US)",
volume = "109",
pages = "1823--1830",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Stroke volume variation during acute normovolemic hemodilution

AU - Kungys, Gudrun

AU - Rose, David D.

AU - Fleming, Neal

PY - 2009/12

Y1 - 2009/12

N2 - BACKGROUND: The intravascular volume of surgical patients should be optimized to avoid complications associated with both overhydration and underresuscitation. In patients undergoing intraoperative acute normovolemic hemodilution, we investigated whether stroke volume variation (SVV) derived from an arterial pressure-based cardiac output (CO) monitor system (FloTrac/Vigileo™, Edwards Lifesciences, Irvine, CA) tracked the changes associated with blood removal and replacement. We further evaluated the correlations between SVV and 3-dimensional (3D) transesophageal echocardiographic (TEE) left ventricular (LV) volume measurements. METHODS: Twenty-five patients had procedures during which acute normovolemic hemodilution was a planned part of the intraoperative management. We defined 7 measurement timepoints: baseline, after the removal of 5%, 10%, and 15% of the estimated blood volume (EBV) and after replacement with an equal volume of 6% hetastarch to -10%, -5%, and baseline EBV. At each timepoint, heart rate and systolic, diastolic, and mean arterial blood pressure were obtained from standard monitors, CO and SVV measurements were obtained from the FloTrac/Vigileo monitor, and TEE images were recorded for subsequent off-line reconstruction and determination of LV end-systolic and end-diastolic volumes. For statistical evaluations, we used a mixed models analysis of variance and Dunnett's test for post hoc comparisons with baseline values. Pearson's correlation was used to examine the relationships between SVV and LV volume. RESULTS: Analysis of variance demonstrated no significant change in heart rate or mean arterial blood pressure over the duration of study. CO decreased from 4.9 ± 0.3 to 4.5 ± 0.3 L/min after removal of 15% of the EBV and then increased to a final value of 5.4 ± 0.3 L/min after replacement of 15% of the EBV. SVV increased from 9.2% ± 0.9% to 20.3% ± 2.0% (P < 0.001) after removal of 15% of the EBV and returned to a final value of 7.2% ± 0.9% after replacement of 15% of the EBV. The indexed LV end-diastolic volume decreased from 42.1 ± 8.3 to 36.9.3 ± 8.3 mL/m (P < 0.001) after removal of 15% of the EBV and then returned to a final volume of 45.9 ± 10.3 mL/m after replacement of 15% of the EBV. The measurements of SVV correlated inversely with the 3D TEE LV volume measurements. CONCLUSIONS: The SVV derived from the FloTrac/Vigileo system changes significantly as blood is removed and replaced during hemodilution. These changes correlate with 3D TEE measurements of LV volume. The utility of SVV in guiding optimization of intravascular volume merits further study.

AB - BACKGROUND: The intravascular volume of surgical patients should be optimized to avoid complications associated with both overhydration and underresuscitation. In patients undergoing intraoperative acute normovolemic hemodilution, we investigated whether stroke volume variation (SVV) derived from an arterial pressure-based cardiac output (CO) monitor system (FloTrac/Vigileo™, Edwards Lifesciences, Irvine, CA) tracked the changes associated with blood removal and replacement. We further evaluated the correlations between SVV and 3-dimensional (3D) transesophageal echocardiographic (TEE) left ventricular (LV) volume measurements. METHODS: Twenty-five patients had procedures during which acute normovolemic hemodilution was a planned part of the intraoperative management. We defined 7 measurement timepoints: baseline, after the removal of 5%, 10%, and 15% of the estimated blood volume (EBV) and after replacement with an equal volume of 6% hetastarch to -10%, -5%, and baseline EBV. At each timepoint, heart rate and systolic, diastolic, and mean arterial blood pressure were obtained from standard monitors, CO and SVV measurements were obtained from the FloTrac/Vigileo monitor, and TEE images were recorded for subsequent off-line reconstruction and determination of LV end-systolic and end-diastolic volumes. For statistical evaluations, we used a mixed models analysis of variance and Dunnett's test for post hoc comparisons with baseline values. Pearson's correlation was used to examine the relationships between SVV and LV volume. RESULTS: Analysis of variance demonstrated no significant change in heart rate or mean arterial blood pressure over the duration of study. CO decreased from 4.9 ± 0.3 to 4.5 ± 0.3 L/min after removal of 15% of the EBV and then increased to a final value of 5.4 ± 0.3 L/min after replacement of 15% of the EBV. SVV increased from 9.2% ± 0.9% to 20.3% ± 2.0% (P < 0.001) after removal of 15% of the EBV and returned to a final value of 7.2% ± 0.9% after replacement of 15% of the EBV. The indexed LV end-diastolic volume decreased from 42.1 ± 8.3 to 36.9.3 ± 8.3 mL/m (P < 0.001) after removal of 15% of the EBV and then returned to a final volume of 45.9 ± 10.3 mL/m after replacement of 15% of the EBV. The measurements of SVV correlated inversely with the 3D TEE LV volume measurements. CONCLUSIONS: The SVV derived from the FloTrac/Vigileo system changes significantly as blood is removed and replaced during hemodilution. These changes correlate with 3D TEE measurements of LV volume. The utility of SVV in guiding optimization of intravascular volume merits further study.

UR - http://www.scopus.com/inward/record.url?scp=73949102940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949102940&partnerID=8YFLogxK

U2 - 10.1213/ANE.0b013e3181ba41af

DO - 10.1213/ANE.0b013e3181ba41af

M3 - Article

VL - 109

SP - 1823

EP - 1830

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -